ConductScience.org, home

Paper34945136

Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.

Rosi E and 5 others. J Clin Med, 2021. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic. Papers, record 34945136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34945136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
PubMed
Journal
J Clin Med
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2021-12-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rosi EEliahttps://orcid.org/0000-0002-4227-7847
2Fastame MTMaria Thais
3Di Cesare AAntonella
4Silvi GGianmarco
5Pimpinelli NNicola
6Prignano FFrancescahttps://orcid.org/0000-0002-5997-2045

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134246359CoronaVac: more data for regulators and policy makers.Lancet2021https://conductscience.org/library/papers/34246359PubMed
234085330Anti-COVID-19 measurements for hidradenitis suppurativa patients.Exp Dermatol2021https://conductscience.org/library/papers/34085330PubMed
334453380COVID-19 and exacerbation of dermatological diseases: A review of the available literature.Dermatol Ther2021https://conductscience.org/library/papers/34453380PubMed
434282868May COVID-19 infection induce a paradoxical improvement of a non-responsive case of hidradenitis suppurativa?Ital J Dermatol Venerol2021https://conductscience.org/library/papers/34282868PubMed
534363647Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre.J Eur Acad Dermatol Venereol2021https://conductscience.org/library/papers/34363647PubMed
633141505Emerging role of anti-IL23 in the treatment of psoriasis: When humanized is very promising.Dermatol Ther2020https://conductscience.org/library/papers/33141505PubMed
732432955Is biologic treatment of hidradenitis suppurativa during the COVID-19 pandemic different from psoriasis biologic treatment?J Dermatolog Treat2022https://conductscience.org/library/papers/32432955PubMed
832594549Compliance, safety concerns and anxiety in patients treated with biologics for psoriasis during the COVID-19 pandemic national lockdown: a multicenter study in the Czech Republic.J Eur Acad Dermatol Venereol2020https://conductscience.org/library/papers/32594549PubMed
933977096NAFLD and Infection, a Nuanced Relationship.Can J Gastroenterol Hepatol2021https://conductscience.org/library/papers/33977096PubMed
1034350668Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.Dermatol Ther2021https://conductscience.org/library/papers/34350668PubMed
1133337329Hidradenitis suppurativa and adalimumab in the COVID-19 era.Eur J Dermatol2020https://conductscience.org/library/papers/33337329PubMed
1233838206Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases.J Am Acad Dermatol2021https://conductscience.org/library/papers/33838206PubMed
1332338424Biologics for psoriasis in COVID-19 era: What do we know?Dermatol Ther2020https://conductscience.org/library/papers/32338424PubMed
1433666256COVID-19 vaccination and patients with psoriasis under biologics: real-life evidence on safety and effectiveness from Italian vaccinated healthcare workers.Clin Exp Dermatol2021https://conductscience.org/library/papers/33666256PubMed
1532406283A survey of psoriasis patients on biologics during COVID-19: a single centre experience.J Dermatolog Treat2022https://conductscience.org/library/papers/32406283PubMed
1634170306Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada.JAMA Netw Open2021https://conductscience.org/library/papers/34170306PubMed
1733609286COVID-19 vaccination intention among patients with psoriasis compared with immunosuppressed patients with other skin diseases and factors influencing their decision.Br J Dermatol2021https://conductscience.org/library/papers/33609286PubMed
1834145643Describing the burden of the COVID-19 pandemic in people with psoriasis: findings from a global cross-sectional study.J Eur Acad Dermatol Venereol2021https://conductscience.org/library/papers/34145643PubMed
1932705945The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.J Dermatolog Treat2022https://conductscience.org/library/papers/32705945PubMed
2033948082Acrodermatitis Continua of Hallopeau Evolving into Generalized Pustular Psoriasis Following COVID-19: A Case Report of a Successful Treatment with Infliximab in Combination with Acitretin.Biologics2021https://conductscience.org/library/papers/33948082PubMed

See all 93 referencesDownload CSV of references

Genes9

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34945136

GET https://conductscience.org/api/papers/v1/34945136/references?page=2